1. Home
  2. ZURA vs AIRT Comparison

ZURA vs AIRT Comparison

Compare ZURA & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • AIRT
  • Stock Information
  • Founded
  • ZURA 2022
  • AIRT 1980
  • Country
  • ZURA United States
  • AIRT United States
  • Employees
  • ZURA N/A
  • AIRT N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • AIRT Air Freight/Delivery Services
  • Sector
  • ZURA Health Care
  • AIRT Consumer Discretionary
  • Exchange
  • ZURA Nasdaq
  • AIRT Nasdaq
  • Market Cap
  • ZURA 61.9M
  • AIRT 53.2M
  • IPO Year
  • ZURA N/A
  • AIRT N/A
  • Fundamental
  • Price
  • ZURA $1.13
  • AIRT $22.22
  • Analyst Decision
  • ZURA Buy
  • AIRT
  • Analyst Count
  • ZURA 7
  • AIRT 0
  • Target Price
  • ZURA $14.33
  • AIRT N/A
  • AVG Volume (30 Days)
  • ZURA 545.9K
  • AIRT 1.2K
  • Earning Date
  • ZURA 08-08-2025
  • AIRT 08-13-2025
  • Dividend Yield
  • ZURA N/A
  • AIRT N/A
  • EPS Growth
  • ZURA N/A
  • AIRT N/A
  • EPS
  • ZURA N/A
  • AIRT N/A
  • Revenue
  • ZURA N/A
  • AIRT $298,215,000.00
  • Revenue This Year
  • ZURA N/A
  • AIRT N/A
  • Revenue Next Year
  • ZURA N/A
  • AIRT N/A
  • P/E Ratio
  • ZURA N/A
  • AIRT N/A
  • Revenue Growth
  • ZURA N/A
  • AIRT 3.36
  • 52 Week Low
  • ZURA $0.97
  • AIRT $14.56
  • 52 Week High
  • ZURA $5.07
  • AIRT $30.60
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 45.37
  • AIRT 65.43
  • Support Level
  • ZURA $1.10
  • AIRT $18.86
  • Resistance Level
  • ZURA $1.37
  • AIRT $24.92
  • Average True Range (ATR)
  • ZURA 0.09
  • AIRT 0.79
  • MACD
  • ZURA 0.00
  • AIRT 0.41
  • Stochastic Oscillator
  • ZURA 37.18
  • AIRT 62.29

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About AIRT Air T Inc.

Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.

Share on Social Networks: